Cupertino, CA, United States of America

Katsuyuki Murase

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Katsuyuki Murase

Introduction

Katsuyuki Murase is a prominent inventor based in Cupertino, CA (US). He has made significant contributions to the field of cardiovascular technology, holding a total of 12 patents. His work focuses on innovative solutions that enhance the treatment and management of cardiovascular diseases.

Latest Patents

Among his latest patents is a composition of bioactive agent-loaded micelles with tissue-targeting properties. This invention outlines methods for utilizing these micelles effectively. Another notable patent involves a method for the sustained release of apolipoprotein A-I mimetic peptides. This method includes advancing a delivery device through a blood vessel lumen to a specific region and introducing a composition that includes a sustained-release carrier and an apo A-I synthetic mimetic peptide. This peptide is designed to facilitate reverse cholesterol transport, showcasing Murase's commitment to advancing cardiovascular health.

Career Highlights

Katsuyuki Murase is currently employed at Abbott Cardiovascular Systems, Inc., where he continues to innovate and develop new technologies. His work has been instrumental in creating solutions that address critical health challenges in the cardiovascular domain.

Collaborations

He collaborates with esteemed colleagues such as Dariush Davalian and Li Zhao, contributing to a dynamic team focused on groundbreaking research and development in cardiovascular technologies.

Conclusion

Katsuyuki Murase's contributions to the field of cardiovascular innovation are noteworthy. His patents and ongoing work at Abbott Cardiovascular Systems, Inc. reflect his dedication to improving health outcomes through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…